Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Arrowhead Research
ARWR
$11.9B
| $6.75M | ﹤0.01% |
191,760
+45,851
| +31% | +$1.72M |
|
1177
Fortune Brands Innovations
FBIN
$5.88B
| $6.71M | ﹤0.01% |
131,185
-77,818
| -37% | -$4.56M |
|
1178
Itaú Unibanco
ITUB
$93.2B
| $6.69M | ﹤0.01% |
1,771,723
+295,949
| +20% | +$1.31M |
|
1179
Dentsply Sirona
XRAY
$2.68B
| $6.66M | ﹤0.01% |
186,263
-185,087
| -50% | -$7.48M |
|
1180
First Citizens BancShares
FCNCA
$24.9B
| $6.64M | ﹤0.01% |
10,156
-7,782
| -43% | -$5.07M |
|
1181
Robert Half
RHI
$3.87B
| $6.64M | ﹤0.01% |
88,639
-40,562
| -31% | -$3.85M |
|
|
LTHM
1182
DELISTED
Livent Corporation
LTHM
| $6.62M | ﹤0.01% |
291,727
-72,990
| -20% | -$1.88M |
|
1183
Huntsman Corp
HUN
$1.71B
| $6.62M | ﹤0.01% |
233,337
+53,436
| +30% | +$1.8M |
|
1184
Tandem Diabetes Care
TNDM
$1.34B
| $6.61M | ﹤0.01% |
111,607
+5,556
| +5% | +$456K |
|
1185
CALL
Salesforce
CRM
$151B
| $6.6M | ﹤0.01% |
+40,000
| New | +$7.07M |
|
|
MTOR
1186
DELISTED
MERITOR, Inc.
MTOR
| $6.6M | ﹤0.01% |
181,682
-36,184
| -17% | -$1.3M |
|
1187
Burford Capital
BUR
$903M
| $6.59M | ﹤0.01% |
653,560
-151,276
| -19% | -$1.33M |
|
1188
Robinhood
HOOD
$77.8B
| $6.58M | ﹤0.01% |
800,809
-187,443
| -19% | -$1.83M |
|
1189
Elanco Animal Health
ELAN
$13.2B
| $6.58M | ﹤0.01% |
335,301
+47,794
| +17% | +$1.13M |
|
1190
Guardant Health
GH
$21.7B
| $6.5M | ﹤0.01% |
161,206
-45,346
| -22% | -$2.25M |
|
1191
Invesco S&P 500 Equal Weight ETF
RSP
$97B
| $6.48M | ﹤0.01% |
48,300
| – | – |
|
1192
RLX Technology
RLX
$2.47B
| $6.46M | ﹤0.01% |
3,030,542
-2,375,131
| -44% | -$4.78M |
|
|
AQNU
1193
DELISTED
Algonquin Power & Utilities Corp Units
AQNU
| $6.46M | ﹤0.01% |
147,512
+56,786
| +63% | +$2.64M |
|
|
SHAP
1194
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $6.45M | ﹤0.01% |
646,576
+51,360
| +9% | +$511K |
|
|
AHRN
1195
DELISTED
Ahren Acquisition Corp
AHRN
| $6.45M | ﹤0.01% |
650,000
| – | – |
|
1196
Restaurant Brands International
QSR
$25.7B
| $6.43M | ﹤0.01% |
128,116
+86,806
| +210% | +$4.64M |
|
1197
CALL
Jabil
JBL
$33B
| $6.42M | ﹤0.01% |
+125,400
| New | +$7.26M |
|
1198
Jazz Pharmaceuticals
JAZZ
$15.9B
| $6.41M | ﹤0.01% |
41,109
+4,623
| +13% | +$712K |
|
|
PENG
1199
Penguin Solutions Inc
PENG
$2.7B
| $6.41M | ﹤0.01% |
391,244
+80,491
| +26% | +$1.83M |
|
1200
Southland Holdings
SLND
$30.2M
| $6.37M | ﹤0.01% |
641,600
+23,400
| +4% | +$232K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 561 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 561 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.